Major factors responsible to drive the market growth include, rising number of gynecological diseases, utilization of artificial intelligence in gynecology and increasing advancements in devices used for women. However, the limited access to contraception is likely to hamper the market growth during forecast period.
The increase in awareness about gynecological diseases leads to the diagnosis and treatment of gynecological cancer. The healthcare service and facilities providers are aiming to offer more advanced equipment and technologies for the treatment. Artificial intelligence (AI) is growing exponentially in various fields, such as gynecology. For instance, in a report by Norwitz et al., an AI software was created to predict prognosis in patients with ovarian cancer more precisely than current methods and effective treatment for every patient’s diagnosis. Researchers at Brigham and Women’s Hospital and Dana-Farber Cancer Institute have been using AI to change large amounts of micro ribonucleic acid (RNA) data to develop models that can potentially diagnose early ovarian cancer. AI can improve patient outcomes, reduce healthcare costs, and decrease the workload for clinicians.
AI has surpassed human experts in interpreting cervical pre-cancer images. AI deep learning algorithms can gather many images related to cervical cancer screening and identify diseased tissue appropriately. It also ensures that the test is convenient, accurate, and cost-effective. It can help surgeons by providing better imaging and spatial awareness before and during gynecological surgeries. Further, AI has helped decrease operative time and accuracy, thereby reducing operative complications using augmented reality. Moreover, robotics is an example of computer systems assisting in surgery. Incorporating robotics by trained gynecologists is boosting the demand for various surgical instruments. With its help, the possibility of switching to a minimally invasive route during surgery becomes easy and can help reduce invasive surgeries, their associated risks, and operation time. Gynecologic robotic surgery uses equipment that helps in minimally invasive surgical procedures. Further, a few robotics can even decrease tremors to promote accuracy during surgery.
Cancer and other gynecologic conditions can be successfully treated with this innovative technology. Moreover, medical device makers are leaning on leveraging the strength of robotics surgeries to expand their profit. Further, the rapidly growing traction of automation technologies, such as robotics, in the treatment of gynecological disorders is expected to boost the growth of the gynecology devices market.
ASIA PACIFIC GYNECOLOGY DEVICES MARKET SEGMENTATION
The Asia Pacific gynecology devices market based on the product is segmented into surgical device, hand instruments, and diagnostic imaging systems. The Asia Pacific gynecology devices market based on the end user is segmented into
hospitals, diagnostic centers, clinics, and others. Geographically, the Asia Pacific gynecology device market is divided into India, China, Japan, South Korea, South Africa, and the Rest of Asia Pacific.
Boston Scientific Corporation; CooperSurgical, Inc; Ethicon; General Electric Company; Hologic, Inc.; KARL STORZ SE & Co. KG; Medtronic; Olympus Corporation; Richard Wolf GmbH.; and Stryker are among the leading companies operating in the Asia Pacific gynecology device market.